Immunoprophylaxis of respiratory syncytial virus disease

Pediatr Infect Dis J. 2000 Aug;19(8):791-801; discussion 802-4. doi: 10.1097/00006454-200008000-00033.
No abstract available

Publication types

  • Review

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Child
  • Child, Preschool
  • Controlled Clinical Trials as Topic
  • Female
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use*
  • Immunotherapy*
  • Infant
  • Male
  • Prognosis
  • Respiratory Syncytial Virus Infections / drug therapy
  • Respiratory Syncytial Virus Infections / immunology
  • Respiratory Syncytial Virus Infections / prevention & control*
  • Risk Assessment
  • Risk Factors
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Antiviral Agents
  • Immunoglobulins, Intravenous
  • respiratory syncytial virus immune globulin intravenous